Stage IIIC2 Uterine Corpus Cancer AJCC v8

7 clinical trials · Condition

Record	Firm	Date
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373)	M.D. Anderson Cancer Center	2022-04-29
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (NCT05269381)	Mayo Clinic	2022-03-31
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors (NCT07259304)	University of Southern California	2021-11-24
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801)	M.D. Anderson Cancer Center	2021-09-30
Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer (NCT04269837)	Ohio State University Comprehensive Cancer Center	2021-05-20
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)	City of Hope Medical Center	2019-12-24
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT03008408)	M.D. Anderson Cancer Center	2017-08-18

Every clearance here is in the API, with alerts when new ones post.